Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

LI-COR

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$25M
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Key employees 1

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Health Care
Summary

LI-COR is the famous Corporate Investor, which was founded in 1971. The main office of represented Corporate Investor is situated in the Lincoln. The fund was located in North America if to be more exact in United States.

The high activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

The standard case for the fund is to invest in rounds with 8 partakers. Despite the LI-COR, startups are often financed by Ysios Capital, Lysosomal Therapeutics, Chiesi Ventures. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Lundbeckfonden Ventures, Columbus Venture Partners. In the next rounds fund is usually obtained by Medicxi Ventures.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Aura Biosciences. Among the most successful fund investment fields, there are Biotechnology, Health Care.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
360networks Seattle, United States, Washington
42CAP Bayern, Germany, Munich
AGC Japan, Tokyo
Angel Labs California, San Francisco, United States
Binux Capital California, Saratoga, United States
Citi Foundation -
Diedai Capital China, Hangzhou, Zhejiang
Espace-inc Canada, Quebec, Sherbrooke
Grafton Capital England, London, United Kingdom
Green River Investments -
Jason Investment China, Futian, Guangdong
Lonza Group Basel, Basel-Stadt, Switzerland
New Amsterdam Capital England, London, United Kingdom
Nikkei Digital Media Japan, Tokyo
Pine Brook Partners New York, New York, United States
Pivotal Asset Management California, San Francisco, United States
Raytheon Massachusetts, United States, Waltham
Salem Investment Partners Greensboro, North Carolina, United States
Startech Early Ventures Richardson, Texas, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Aura Biosciences

Biotechnology
Health Care
Pharmaceutical
$30M21 Dec 2017 Cambridge, Massachusetts, United States

Aura Biosciences

Biotechnology
Health Care
Pharmaceutical
$21M05 Mar 2015 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent LI-COR?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 25M
Rounds per year 0.04
Peak activity year 2015
Lead investments 0
Follow on index 0.50
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Aura Biosciences

Biotechnology
Health Care
Pharmaceutical
$30M21 Dec 2017 Cambridge, Massachusetts, United States

Aura Biosciences

Biotechnology
Health Care
Pharmaceutical
$21M05 Mar 2015 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: